Literature DB >> 23981302

NFκB-mediated cyclin D1 expression by microRNA-21 influences renal cancer cell proliferation.

Amit Bera1, Nandini Ghosh-Choudhury, Nirmalya Dey, Falguni Das, Balakuntalam S Kasinath, Hanna E Abboud, Goutam Ghosh Choudhury.   

Abstract

MicroRNAs regulate post-transcriptomic landscape in many tumors including renal cell carcinoma. We have recently shown significantly increased expression of miR-21 in renal tumors and that this miRNA contributes to the proliferation of renal cancer cells in culture. However, the mechanism by which miR-21 regulates renal cancer cell proliferation is poorly understood. Addiction to constitutive NFκB activity is hallmark of many cancers including renal cancer. Using miR-21 Sponge in renal cancer cells to block endogenous function of miR-21, we show inhibition of phosphorylation of p65 subunit of NFκB, IKKβ and IκB, which results in attenuation of NFκB transcriptional activity. Subtle reduction in the tumor suppressor PTEN has been linked to various malignancies. We showed previously that miR-21 targeted PTEN in renal cancer cells. Inhibition of PTEN by siRNAs restored miR-21 Sponge-induced suppression of phosphorylation of p65, IKKβ, IκB and NFκB transcriptional activity along with reversal of miR-21 Sponge-reduced phosphorylation of Akt. Expression of constitutively active Akt protected against miR-21 Sponge- and PTEN-mediated decrease in p65/IKKβ/IκB phosphorylation and NFκB transcriptional activity. Furthermore, IKKβ and p65 were required for miR-21-induced renal cancer cell proliferation. Interestingly, miR-21 controlled the expression of cyclin D1 through NFκB-dependent transcription. Finally, we demonstrate that miR-21-regulated renal cancer cell proliferation is mediated by cyclin D1 and CDK4. Together, our results establish a molecular order of a phosphatase-kinase couple involving PTEN/Akt/IKKβ and NFκB-dependent cyclin D1 expression for renal carcinoma cell proliferation by increased miR-21 levels.
© 2013.

Entities:  

Keywords:  MicroRNA; NFκB; PTEN; Renal cancer

Mesh:

Substances:

Year:  2013        PMID: 23981302      PMCID: PMC3896302          DOI: 10.1016/j.cellsig.2013.08.005

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  68 in total

1.  Oncostatin M induces growth arrest of skeletal muscle cells in G1 phase by regulating cyclin D1 protein level.

Authors:  Hyuck Kim; Chulman Jo; Bong Geom Jang; Uhtaek Oh; Sangmee Ahn Jo
Journal:  Cell Signal       Date:  2007-10-03       Impact factor: 4.315

2.  NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN.

Authors:  Xinjiang Wang; Lloyd C Trotman; Theresa Koppie; Andrea Alimonti; Zhenbang Chen; Zhonghua Gao; Junru Wang; Hediye Erdjument-Bromage; Paul Tempst; Carlos Cordon-Cardo; Pier Paolo Pandolfi; Xuejun Jiang
Journal:  Cell       Date:  2007-01-12       Impact factor: 41.582

3.  Unrestrained mammalian target of rapamycin complexes 1 and 2 increase expression of phosphatase and tensin homolog deleted on chromosome 10 to regulate phosphorylation of Akt kinase.

Authors:  Falguni Das; Nandini Ghosh-Choudhury; Nirmalya Dey; Chandi Charan Mandal; Lenin Mahimainathan; Balakuntalam S Kasinath; Hanna E Abboud; Goutam Ghosh Choudhury
Journal:  J Biol Chem       Date:  2011-12-19       Impact factor: 5.157

4.  DJ-1, a novel regulator of the tumor suppressor PTEN.

Authors:  Raymond H Kim; Malte Peters; YingJu Jang; Wei Shi; Melania Pintilie; Graham C Fletcher; Carmela DeLuca; Jennifer Liepa; Lily Zhou; Bryan Snow; Richard C Binari; Armen S Manoukian; Mark R Bray; Fei-Fei Liu; Ming-Sound Tsao; Tak W Mak
Journal:  Cancer Cell       Date:  2005-03       Impact factor: 31.743

5.  Subtle variations in Pten dose determine cancer susceptibility.

Authors:  Andrea Alimonti; Arkaitz Carracedo; John G Clohessy; Lloyd C Trotman; Caterina Nardella; Ainara Egia; Leonardo Salmena; Katia Sampieri; William J Haveman; Edi Brogi; Andrea L Richardson; Jiangwen Zhang; Pier Paolo Pandolfi
Journal:  Nat Genet       Date:  2010-04-18       Impact factor: 38.330

6.  Cyclin D1 expression in renal carcinomas and oncocytomas: an immunohistochemical study.

Authors:  B T Lin; R K Brynes; A B Gelb; A McCourty; M B Amin; L J Medeiros
Journal:  Mod Pathol       Date:  1998-11       Impact factor: 7.842

Review 7.  The role of ubiquitin in NF-kappaB regulatory pathways.

Authors:  Brian Skaug; Xiaomo Jiang; Zhijian J Chen
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

Review 8.  Structural basis for activation and inhibition of class I phosphoinositide 3-kinases.

Authors:  Oscar Vadas; John E Burke; Xuxiao Zhang; Alex Berndt; Roger L Williams
Journal:  Sci Signal       Date:  2011-10-18       Impact factor: 8.192

9.  microRNA-21 governs TORC1 activation in renal cancer cell proliferation and invasion.

Authors:  Nirmalya Dey; Falguni Das; Nandini Ghosh-Choudhury; Chandi Charan Mandal; Dipen J Parekh; Karen Block; Balakuntalam S Kasinath; Hanna E Abboud; Goutam Ghosh Choudhury
Journal:  PLoS One       Date:  2012-06-04       Impact factor: 3.240

10.  Cyclin D1/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice.

Authors:  H Lovec; A Grzeschiczek; M B Kowalski; T Möröy
Journal:  EMBO J       Date:  1994-08-01       Impact factor: 11.598

View more
  22 in total

1.  A positive feedback loop involving Erk5 and Akt turns on mesangial cell proliferation in response to PDGF.

Authors:  Amit Bera; Falguni Das; Nandini Ghosh-Choudhury; Xiaonan Li; Sanjay Pal; Yves Gorin; Balakuntalam S Kasinath; Hanna E Abboud; Goutam Ghosh Choudhury
Journal:  Am J Physiol Cell Physiol       Date:  2014-04-16       Impact factor: 4.249

2.  Reciprocal regulation of miR-214 and PTEN by high glucose regulates renal glomerular mesangial and proximal tubular epithelial cell hypertrophy and matrix expansion.

Authors:  Amit Bera; Falguni Das; Nandini Ghosh-Choudhury; Meenalakshmi M Mariappan; Balakuntalam S Kasinath; Goutam Ghosh Choudhury
Journal:  Am J Physiol Cell Physiol       Date:  2017-07-12       Impact factor: 4.249

3.  High glucose enhances microRNA-26a to activate mTORC1 for mesangial cell hypertrophy and matrix protein expression.

Authors:  Nirmalya Dey; Amit Bera; Falguni Das; Nandini Ghosh-Choudhury; Balakuntalam S Kasinath; Goutam Ghosh Choudhury
Journal:  Cell Signal       Date:  2015-03-20       Impact factor: 4.315

Review 4.  MiRNAs in renal cell carcinoma.

Authors:  Jesús Miranda-Poma; Lucía Trilla-Fuertes; Elena López-Camacho; Andrea Zapater-Moros; Rocío López-Vacas; María Isabel Lumbreras-Herrera; Ana Pertejo-Fernandez; Juan Ángel Fresno-Vara; Enrique Espinosa-Arranz; Angelo Gámez-Pozo; Álvaro Pinto-Marín
Journal:  Clin Transl Oncol       Date:  2022-06-21       Impact factor: 3.340

5.  T-cell factor (TCF/LEF1) binding elements (TBEs) of FasL (Fas ligand or CD95 ligand) bind and cluster Fas (CD95) and form complexes with the TCF-4 and b-catenin transcription factors in vitro and in vivo which result in triggering cell death and/or cell activation.

Authors:  Xia Liu; Yuwei Huang; Yuanyuan Zhang; Xiaohong Li; Chun Liu; Shen Huang; Dezhi Xu; Yang Wu; Xiaojuan Liu
Journal:  Cell Mol Neurobiol       Date:  2016-04-18       Impact factor: 5.046

6.  microRNA-21-induced dissociation of PDCD4 from rictor contributes to Akt-IKKβ-mTORC1 axis to regulate renal cancer cell invasion.

Authors:  Amit Bera; Falguni Das; Nandini Ghosh-Choudhury; Balakuntalam S Kasinath; Hanna E Abboud; Goutam Ghosh Choudhury
Journal:  Exp Cell Res       Date:  2014-07-09       Impact factor: 3.905

7.  LINC00473 antagonizes the tumour suppressor miR-195 to mediate the pathogenesis of Wilms tumour via IKKα.

Authors:  Shibo Zhu; Wen Fu; Liyu Zhang; Kai Fu; Jinhua Hu; Wei Jia; Guochang Liu
Journal:  Cell Prolif       Date:  2017-11-20       Impact factor: 6.831

8.  Pseudogene PTENP1 functions as a competing endogenous RNA to suppress clear-cell renal cell carcinoma progression.

Authors:  Gan Yu; Weimin Yao; Kiranmai Gumireddy; Anping Li; Ji Wang; Wei Xiao; Ke Chen; Haibing Xiao; Heng Li; Kun Tang; Zhangqun Ye; Qihong Huang; Hua Xu
Journal:  Mol Cancer Ther       Date:  2014-09-23       Impact factor: 6.261

9.  Direct reprogramming of human fibroblasts into sweat gland-like cells.

Authors:  Zhiliang Zhao; Mengyao Xu; Meng Wu; Kui Ma; Mengli Sun; Xiaocheng Tian; Cuiping Zhang; Xiaobing Fu
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

10.  MicroRNA-214 Reduces Insulin-like Growth Factor-1 (IGF-1) Receptor Expression and Downstream mTORC1 Signaling in Renal Carcinoma Cells.

Authors:  Falguni Das; Nirmalya Dey; Amit Bera; Balakuntalam S Kasinath; Nandini Ghosh-Choudhury; Goutam Ghosh Choudhury
Journal:  J Biol Chem       Date:  2016-05-13       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.